{"id":8268,"date":"2026-04-15T10:24:04","date_gmt":"2026-04-15T10:24:04","guid":{"rendered":"https:\/\/www.seaspringconsulting.com\/?p=8268"},"modified":"2026-04-19T10:27:37","modified_gmt":"2026-04-19T10:27:37","slug":"gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care","status":"publish","type":"post","link":"https:\/\/www.seaspringconsulting.com\/ar\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/","title":{"rendered":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care"},"content":{"rendered":"

GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the adoption of personalized, data-driven medicine. Through this collaboration, GNQ will deliver its causal AI Drug Assessment, Drug Simulation, and Digital Twin platforms supported by IBM\u2019s consulting expertise and hybrid cloud deployment experience. The collaboration is formalized through a global Joint Initiative Marketing Agreement signed in March 2026.<\/p>","protected":false},"excerpt":{"rendered":"

GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the adoption of personalized, data-driven medicine.…<\/a><\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[93,4],"tags":[],"class_list":["post-8268","post","type-post","status-publish","format-standard","hentry","category-healthcare","category-news"],"acf":[],"yoast_head":"\nGNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seaspringconsulting.com\/ar\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring\" \/>\n<meta property=\"og:description\" content=\"GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the adoption of personalized, data-driven medicine....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.seaspringconsulting.com\/ar\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Seaspring\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-15T10:24:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-19T10:27:37+00:00\" \/>\n<meta name=\"author\" content=\"Lakshmy Venkat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@seaspringwll\" \/>\n<meta name=\"twitter:site\" content=\"@seaspringwll\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lakshmy Venkat\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/\"},\"author\":{\"name\":\"Lakshmy Venkat\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/person\\\/32694aa2722e4e7a253a30ddbecacca6\"},\"headline\":\"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care\",\"datePublished\":\"2026-04-15T10:24:04+00:00\",\"dateModified\":\"2026-04-19T10:27:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/\"},\"wordCount\":89,\"publisher\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\"},\"articleSection\":[\"Healthcare\",\"News\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/\",\"name\":\"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#website\"},\"datePublished\":\"2026-04-15T10:24:04+00:00\",\"dateModified\":\"2026-04-19T10:27:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#website\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\",\"name\":\"Seaspring\",\"description\":\"Link Forward\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\",\"name\":\"Seaspring W.L.L.\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/94a121.p3cdn1.secureserver.net\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SeaSpring-Primary-Logo-Original.png?time=1668334512\",\"contentUrl\":\"https:\\\/\\\/94a121.p3cdn1.secureserver.net\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SeaSpring-Primary-Logo-Original.png?time=1668334512\",\"width\":1412,\"height\":408,\"caption\":\"Seaspring W.L.L.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/seaspringwll\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/person\\\/32694aa2722e4e7a253a30ddbecacca6\",\"name\":\"Lakshmy Venkat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"caption\":\"Lakshmy Venkat\"},\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/ar\\\/author\\\/lakshmy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seaspringconsulting.com\/ar\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/","og_locale":"ar_AR","og_type":"article","og_title":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring","og_description":"GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the adoption of personalized, data-driven medicine....","og_url":"https:\/\/www.seaspringconsulting.com\/ar\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/","og_site_name":"Seaspring","article_published_time":"2026-04-15T10:24:04+00:00","article_modified_time":"2026-04-19T10:27:37+00:00","author":"Lakshmy Venkat","twitter_card":"summary_large_image","twitter_creator":"@seaspringwll","twitter_site":"@seaspringwll","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Lakshmy Venkat","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/#article","isPartOf":{"@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/"},"author":{"name":"Lakshmy Venkat","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/person\/32694aa2722e4e7a253a30ddbecacca6"},"headline":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care","datePublished":"2026-04-15T10:24:04+00:00","dateModified":"2026-04-19T10:27:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/"},"wordCount":89,"publisher":{"@id":"https:\/\/www.seaspringconsulting.com\/#organization"},"articleSection":["Healthcare","News"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/","url":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/","name":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care - Seaspring","isPartOf":{"@id":"https:\/\/www.seaspringconsulting.com\/#website"},"datePublished":"2026-04-15T10:24:04+00:00","dateModified":"2026-04-19T10:27:37+00:00","breadcrumb":{"@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seaspringconsulting.com\/gnq-insilico-plans-to-accelerate-precision-medicine-and-clinical-ai-adoption-across-drug-development-and-patient-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.seaspringconsulting.com\/"},{"@type":"ListItem","position":2,"name":"GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care"}]},{"@type":"WebSite","@id":"https:\/\/www.seaspringconsulting.com\/#website","url":"https:\/\/www.seaspringconsulting.com\/","name":"Seaspring","description":"Link Forward","publisher":{"@id":"https:\/\/www.seaspringconsulting.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seaspringconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/www.seaspringconsulting.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0633\u064a\u0633\u0628\u0631\u064a\u0646\u063a \u0630.\u0645.\u0645.","url":"https:\/\/www.seaspringconsulting.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/94a121.p3cdn1.secureserver.net\/wp-content\/uploads\/2022\/10\/SeaSpring-Primary-Logo-Original.png?time=1668334512","contentUrl":"https:\/\/94a121.p3cdn1.secureserver.net\/wp-content\/uploads\/2022\/10\/SeaSpring-Primary-Logo-Original.png?time=1668334512","width":1412,"height":408,"caption":"Seaspring W.L.L."},"image":{"@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/seaspringwll"]},{"@type":"Person","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/person\/32694aa2722e4e7a253a30ddbecacca6","name":"Lakshmy Venkat","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","caption":"Lakshmy Venkat"},"url":"https:\/\/www.seaspringconsulting.com\/ar\/author\/lakshmy\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/8268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/comments?post=8268"}],"version-history":[{"count":2,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/8268\/revisions"}],"predecessor-version":[{"id":8270,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/8268\/revisions\/8270"}],"wp:attachment":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/media?parent=8268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/categories?post=8268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/tags?post=8268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}